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SUMMARY
The construction of the first stable human cell lines that express and secrete authentic hepatitis B virus surface antigen (HBsAg), using a BK virus (BKV) episomal plasmid vector, is described. The amount of HBsAg produced by BKV vectors (up to 600 ng/10 ~ cells) was comparable to other eukaryotic vector systems. The level of HBsAg expression remained the same regardless of the orientation of the HBsAg gene, substitution of the HBsAg gene promoter with the mouse metallothionein I gene promoter or the tissue origin of the human cell lines used to establish stable cellular transformants. Northern blot analysis also indicated synthesis of normal HBsAg transcripts. Surprisingly, however, the vectors were maintained at far lower than expected copy number (one to five copies/cell). Reasons for this are discussed.
Hepatitis B virus (HBV) causes acute and chronic liver disease and has been implicated in hepatocellular carcinoma. The HBV surface antigen (HBsAg), present on the viral envelope, induces the immune response during infection (Tiollais et al., 1985) . Due to the difficulty in propagating HBV in tissue culture, several eukaryotic vector systems have been used to study the transcription and expression of the HBV genome (Feitelson, 1985) . These vector systems are also useful in obtaining purified HBV antigens for viral vaccines. However, in no case have stable episomal vector-transformed human cell lines been described which synthesize the HBsAg. Generation of human viral vaccine in a human cell line is preferable to using cell lines from other species since potential contamination by foreign cellular proteins in the purification is obviated. In this study the BK virus (BKV) plasmid vector pBK, which has been shown to reside as a stable episome in human cells (Milanesi et al., 1984) , was used to obtain human cell lines that express HBsAg.
Vectors were constructed as described in the legend to Fig. 1 using standard cloning procedures (Maniatis et at., 1982) . Vectors pBK-H 1, pBK-H2 and pBK-TK-H2 were derived from pBK or pBK-TK (Milanesi et al., 1984) . In vectors pBK-MT-H3 and pBK-TK-MT-H4 the endogenous promoter of HBsAg gene was substituted by the mouse metallothionein I (MT-I) gene promoter. All cell lines were of human origin, namely 143B thymidine kinase-deficient (TK-) derived from an osteosarcoma (Croce et al., 1979) , HeLa TK-derived from a cervical carcinoma, 293 originated from embryonic kidney cells transformed with adenovirus 5 (Graham et al., 1977) and PLC-PRC-5 hepatoma cells (Alexander et al., 1976) , and were maintained in culture as described in the specific references. Cell monolayers (about 107 cells) were transfected (Wigler et al., 1979) with 10 ~tg of each BKV-HBsAg plasmid. To select for TK ÷ transformants, 143B and HeLa TK-cells were transfected with plasmids containing the herpes simplex virus type 1 (HSV-1) TK gene and maintained in HAT medium (Littlefield, 1965 Galibert et al., 1979; Tiollais et al., 1981) , containing the S coding and 3' non-coding sequences, was substituted for the gB gene (Xhol BamHI fragment) in pBK-MT-gB. In pBK-MT-H3, the XhoI site is immediately upstream of the AUG translational starting codon of the S gone. Therefore, in this construct, transcription of the S gene is directed by the MT-I gene promoter. (c) The pBK-TK-MT-H4 plasmid was obtained by inserting the 5.3 kb EcoRI fragment, derived from pJYMMT(E)HBV (Hsiung et al., 1984) resistance to the antibiotic G418, cells were cotransfected with one of the BKV-HBsAg plasmids and pSV2neo DNA (Southern & Berg, 1982) , at a ratio of 10 : 1, and maintained in the presence of G418 (Sigma; 400 pg/ml). Resulting colonies were individually cloned and expanded into cell lines. HBsAg was detected in the culture supernatant fluid and cell extracts by radioimmunoassay (RIA) or ELISA (Ausria II or Auszime Monoclonal; Abbott Laboratories, North Chicago, II1., U.S.A.); the clones positive for HBsAg were maintained in culture and examined several times for HBsAg expression and state of plasmid DNA over a period of at least 6 months. For quantification of secreted HBsAg, cells were split into new cultures, incubated for 6 days in growth medium and, at the sixth day, 200 ~tl of medium or cell lysate was assayed for HBsAg and the cells were counted. The amounts of HBsAg for the different cell lines correspond to ranges from three to eight clones. Density determination of HBsAg was by CsC1 gradient analysis (Shih et al., 1984) . Aliquots (200 ~tl) of fractions (500 ~tl) were assayed for HBsAg and CsC1 density was determined by refractometry. For immunoprecipitation, celt monotayers were labelled overnight with 500~tCi/12 × 106 cells of [3SS]methionine (Amersham; 400 Ci/mmol), the medium was concentrated by ultrafiltration (Minicon-B 15, Amicon), reacted with a mouse IgG monoclonal antibody to HBsAg and analysed on an SDS-polyacrylamide gel (Laemmli, 1970; Bonner & Laskey, 1974) . The MT promoter was induced with CdSO4 according to Mayo et al. (1982) . Total cellular and low tool. wt. DNA extraction and Southern blotting were carried out as described (Milanesi et al., 1984) . For Northern blot analysis, total and poly(A) ÷ RNA were separated on 1 ~ agarose-6~ formaldehyde gels and hybridized as described (Vasavada et al., 1986) . R N A dot blot analysis was performed as described (White & Bancroft, 1982) . Human T K -143B osteosarcoma cells were transfected with pBK-TK-H2 D N A (Fig. 1 a) and selected in H A T medium. Out of 22 TK ÷ stable derived clones, 14 secreted HBsAg into the culture medium, as determined by RIA; five of these positive clones were further assayed. The amount of HBsAg secreted into the medium in 6 days ranged between 100 and 600 ng per 107 cells. Negligible amounts of HBsAg were detected in the cell lysate. Production of authentic HBsAg was verified by the observations that (i) HBsAg from the culture supernatants banded in isopycnic CsC1 density gradients at a density of 1-2 g/ml (Fig. 2a) and (ii) immunoprecipitation of concentrated culture medium with an HBsAg-specific monoclonal antibody revealed the 24K and 27K proteins, encoded by the S gene (Fig. 2b) , but none of the higher mot. wt. products coded by the pre-S1 and -$2 sequences. Moreover, electron microscope analysis of the banded material indicated the presence of particles 20 to 25 nm in diameter characteristic of human infected serum (not shown). The time course of accumulation of HBsAg is shown for several transformants in Fig. 2(c) . The amount of HBsAg detected in the culture medium of 143B stable cell lines remained the same regardless of whether these cells were grown in the absence of H A T (data not shown), or whether stable cell lines were derived from cotransfections with pBK-H2 (Fig. 1 a) and pSV2neo DNA.
No consistent increase in HBsAg production was obtained with different cell types stably transformed after transfection by plasmids pBK-TK-H2 and pBK-H2. These host cell lines The state of the recombinant DNA molecules in stable clones was analysed by Southern blot hybridization using pBK-H2 as the probe. Fig. 3 shows the results for 14 clones of 143B, HeLa and 293 cells, transfected with pBK-TK-H2 and pBK-H2 plasmids. The plasmids were linearized by Sail digestion (Fig. 3a, lanes 1, 2, 11 and 19 ). Similar length bands that comigrated with the control plasmids were produced by SalI digestion of the low mol. wt. or total cellular DNAs (Fig. 3a, lanes 3 to 10, 13 to 18 ). These results, together with the analysis of the undigested DNAs (not shown), indicate that the transfected plasmids are maintained in a free state and not rearranged in human cells. Densitometric analysis of these DNAs in comparison to known quantities of plasmid DNA showed that one to five genome equivalents (g.e.) of episomal recombinant plasmid were present per cell. The recombinant DNA vectors were sensitive to digestion with MboI (Fig. 3b, lanes 1 to 10) , which specifically cleaves DNA that has replicated in eukaryotic cells, whereas the same DNAs were resistant to digestion with the isoschizomer DpnI (not shown), demonstrating that the episomal recombinant molecules replicate in human cells. Furthermore, Hirt supernatant DNA from HeLa cell clones transformed by pBK-TK-H2 was able to transform Escherichia coli C600 to the ampicillinresistant phenotype, confirming that BKV-HBsAg plasmid DNA persists as a stable episome in human cells. Restriction endonuclease analysis of DNA from several bacterial colonies showed that pBK-TK-H2 DNA was not rearranged (not shown).
A major HBV-specific transcript of approximately 2.3 kb, corresponding to the reported length of HBsAg mRNA (Pourcel et al., 1982; Tiollais et al., 1985) , was observed by Northern blot analysis of RNA from 143B, 293 and HeLa cells transfected with pBK-H2 or pBK-TK-H2 using 3:p-labelled HBsAg DNA as the probe (Fig. 4a, lanes 2 , 3, 5, 6, 8 and 9) . In addition, three minor transcripts of about 6.4, 4.7 and 0.7 kb were detected in three different clones of 143B cells (Fig. 4a, lanes 2, 3 and 9) . Although the origin of these minor transcripts is not clear, the 0.7 kb transcript could correspond to the RNA, synthesized in vitro by RNA polymerase III, that maps between the surface and core antigen coding sequences on the HBV genome (Standring et al., 1983) . In non-transfected cells, no bands corresponding to the HBsAg transcript were detected (Fig. 4a, lanes l, 4 and 7) . In order to compare the amount of HBsAg transcripts to the transcript of the housekeeping cellular dihydrofolate reductase (DHFR) gene, RNA from a HeLa pBK-TK-H2 cell transformant and from normal HeLa cells was hybridized to HBsAg DNA (Fig. 4b , columns 1 and 2) and DHFR DNA probes (Fig. 4b, columns 3 and 4) . Also shown is hybridization to HSV-1 TK DNA (Fig. 4b , columns 5 and 6) as well as to BKV DNA probes (Fig. 4b, columns 7 and 8 ). An equivalent amount of endogenous DHFR RNA was detectable in transformed and untransformed cells (Fig. 4b, columns 3 and 4) , and the amount of HBsAg, DHFR, TK and BKV transcripts in transformed cells was similar (Fig. 4b, columns 1, 3 , 5 and 7). Since the steady-state level of DHFR transcripts is about 100 molecules per cell (Morandi et al., 1982; Riva et al., 1986) , we conclude that HBsAg transcripts are maintained at a comparable level by pBK-TK-H2 in HeLa cells.
We describe here the construction of the first stable human cell lines that express and secrete authentic HBsAg, using a BKV episomal plasmid vector. The amount of HBsAg produced by BKV vectors is comparable to other eukaryotic vectors systems, e.g. bovine papillomavirus (BPV), murine sarcoma virus and simian virus 40 (SV40) (Stratowa et al., 1982; Denniston et al., 1984; Will et al., 1984) . The orientation of the HBsAg gene relative to the BKV sequences, the type of HBsAg gene promoter, the HBV subtype as well as the tissue origin of the human cell clones did not determine major differences in copy number or level of expression of the HBsAg gene using different BKV plasmid constructs.
The low amplification of the pBK-HBsAg plasmids in human cells was unexpected since the progenitor pBK vector was shown to occur at a frequency of 40 to 100 copies per cell in HeLa and 143B cells (Milanesi et al., 1984) . Moreover, pBK vectors containing the HSV-1 glycoprotein B or/?-interferon genes amplify as episomal molecules at 40 to 1000 copies per cell in 293 and HeLa cells (R. Manservigi et al., unpublished results; G. Milanesi, unpublished results) . One possible explanation for the low copy number of the pBK-HBsAg plasmids is the small amount of BKV T antigen, a viral protein necessary for DNA replication (Tegtmeyer, 1980) , synthesized in transformed cell clones; T antigen was detected by ELISA but not by (Morandi et al., 1982) , columns 5 and 6 to HSV-1 TK gene, and columns 7 and 8 to BKV DNA.
All probes had the same specific activity and equal amounts of radioactivity were used for hybridization.
immunofluorescence. Alternatively, sequences in the HBsAg gene might inhibit the amplification of pBK plasmid DNA. Recently, Roberts & Weintraub (1986) showed that specific sequences of BPV DNA repress replication of a composite BPV-SV40 plasmid in COS cells and this negative control on replication was due to both cis-and trans-acting sequences from BPV. Similarly, sequences in the HBsAg gene might reduce plasmid amplification when linked to BKV sequences. In that case, S gene-coding sequences are probably responsible for the effect, since pBK-MT-H3 does not contain the pre-S1 and -$2 regions (Fig. 1 b) , and pBK-TK-MT-H4 contains neither the pre-S1 and -$2 nor the 3' non-coding regions (Fig. l c) . Analysis of amplification of S gene deletion mutants cloned in the pBK vector would address this possibility.
